REGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INC

REGENERON PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

17853.270.00 0.00%
The 23 analysts offering 1 year price forecasts for REGN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 29 analysts giving stock ratings to REGN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

REGN EPS for the last quarter is 158.27 MXN despite the estimation of 168.56 MXN. In the next quarter EPS is expected to reach 184.61 MXN. Track more of REGENERON PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter REGENERON PHARMACEUTICALS INC revenue is expected to reach ‪57.46 B‬ MXN. Check out REGENERON PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, REGN price target is 17853.27 MXN with a max estimate of 20127.73 MXN and a min estimate of 12229.51 MXN. Check if this forecast comes true in a year, meanwhile watch REGENERON PHARMACEUTICALS INC stock price chart and keep track of the current situation with REGN news and stock market news.
We've gathered opinions of 29 analysts rating REGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.